Eris Lifesciences Limited (NSE:ERIS)
India · Delayed Price · Currency is INR 1,332.10
+6.10 (0.46%)
Aug 21, 2026, 3:29 PM IST
Eris Lifesciences Market Cap
Eris Lifesciences has a market cap or net worth of 184.05 billion as of August 21, 2026. Its market cap has decreased by -23.03% in one year.
Market Cap
184.05B
Enterprise Value
206.89B
Revenue
32.12B
Ranking
n/a
PE Ratio
28.35
Stock Price
1,332.10
ChartMarket Cap Chart
Since June 29, 2017, Eris Lifesciences's market cap has increased from 82.71B to 184.05B, an increase of 122.53%. That is a compound annual growth rate of 9.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 184.05B | -10.26% |
| Dec 31, 2025 | 205.09B | 9.67% |
| Dec 31, 2024 | 187.00B | 51.07% |
| Dec 29, 2023 | 123.79B | 40.63% |
| Dec 30, 2022 | 88.02B | -14.80% |
| Dec 31, 2021 | 103.31B | 31.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ajanta Pharma | 454.74B |
| Emcure Pharmaceuticals | 353.21B |
| Wockhardt | 306.51B |
| Piramal Pharma | 283.58B |
| Cohance Lifesciences | 177.13B |
| Alivus Life Sciences | 165.81B |
| Alembic Pharmaceuticals | 161.53B |
| NATCO Pharma | 158.05B |